Century Therapeutics Inc (IPSC)

$0.59 +0.03 (4.76%)
Market Cap 47.97M
Revenue (ttm) 6.59M
Net Income (ttm) -126.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,920.64%
Debt to Equity Ratio 0.00
Volume 1,045,455
Avg Vol 652,438
Day's Range N/A - N/A
Shares Out 86.39M
Stochastic %K 78%
Beta 1.78
Analysts Strong Sell
Price Target $4.40

Company Profile

Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed and refractory B-cell lymphoma. The company is also involved in the development of CNTY...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 817 5790
Address:
25 North 38th Street, 11th Floor, Philadelphia, United States
Invest2live
Invest2live Oct. 8 at 5:04 PM
$CUE $IPSC $LCTX $IPSC 16% already; congrats 🎊🎉🎈🌿 Checkout $CUE and $LCTX
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 8 at 3:51 PM
$IPSC looking good .... break of .60/.62 sends this to .70s this month.
0 · Reply
carpediemjk
carpediemjk Oct. 8 at 2:22 PM
$IPSC Let's go!
0 · Reply
cavindp
cavindp Oct. 8 at 2:18 PM
$IPSC
0 · Reply
Jnutz14
Jnutz14 Oct. 8 at 10:58 AM
$IPSC It is Time!!
0 · Reply
Icarus81
Icarus81 Oct. 8 at 7:32 AM
$IPSC 160m cash + MarketCap 48m + catalyst EOY 👀
0 · Reply
deepgill43
deepgill43 Oct. 8 at 4:48 AM
$IPSC tomorrow is gonna be very interesting day
0 · Reply
BreakoutBuy
BreakoutBuy Oct. 7 at 9:37 PM
I called $RVPH before the run, can $IPSC pop next? 🤨
1 · Reply
BreakoutBuy
BreakoutBuy Oct. 7 at 9:03 PM
$IPSC Some hits in After hours, this wants higher
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 7 at 7:54 PM
$IPSC some more volume into close. Trading way under cash..... this has 2 catalysts ahead. Phase 1 and IND
0 · Reply
Latest News on IPSC
Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Aug 22, 2025, 8:00 AM EDT - 6 weeks ago

Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 4:01 PM EDT - 7 weeks ago

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

May 28, 2025, 4:01 PM EDT - 4 months ago

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 4:01 PM EDT - 5 months ago

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Apr 28, 2025, 4:30 PM EDT - 5 months ago

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Mar 19, 2025, 4:01 PM EDT - 7 months ago

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 7:00 AM EST - 11 months ago

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 5, 2024, 9:05 AM EST - 1 year ago

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference

Nov 4, 2024, 7:00 AM EST - 1 year ago

Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 8, 2024, 7:30 AM EDT - 1 year ago

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101

Jun 20, 2024, 11:07 AM EDT - 1 year ago

Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 9, 2024, 7:30 AM EDT - 1 year ago

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Apr 11, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Apr 8, 2024, 4:05 PM EDT - 1 year ago

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

Mar 14, 2024, 7:30 AM EDT - 1 year ago

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 5, 2024, 6:03 PM EST - 1 year ago

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Feb 1, 2024, 7:00 AM EST - 1 year ago

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Dec 9, 2023, 12:00 PM EST - 1 year ago

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

Dec 6, 2023, 7:30 AM EST - 2 years ago

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

Dec 6, 2023, 7:30 AM EST - 2 years ago

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 21, 2023, 7:00 AM EST - 2 years ago

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Nov 9, 2023, 7:01 AM EST - 2 years ago

Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases

Nov 9, 2023, 7:00 AM EST - 2 years ago

Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

Sep 26, 2023, 7:00 AM EDT - 2 years ago

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

Aug 9, 2023, 7:30 AM EDT - 2 years ago

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

May 11, 2023, 7:30 AM EDT - 2 years ago

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

Century Therapeutics to Present at Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

Apr 17, 2023, 7:00 AM EDT - 2 years ago

Century Therapeutics to Present at Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

Century Therapeutics Announces Leadership Changes

Apr 12, 2023, 8:30 AM EDT - 2 years ago

Century Therapeutics Announces Leadership Changes

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

Mar 16, 2023, 7:30 AM EDT - 2 years ago

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

Century Therapeutics to Present at the AACR Annual Meeting 2023

Mar 15, 2023, 4:01 PM EDT - 2 years ago

Century Therapeutics to Present at the AACR Annual Meeting 2023

Century Therapeutics to Present at Upcoming Investor Conferences

Feb 21, 2023, 7:00 AM EST - 2 years ago

Century Therapeutics to Present at Upcoming Investor Conferences

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

Feb 8, 2023, 7:30 AM EST - 2 years ago

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

5 Health Care Stocks That Are Diving - And May Rally

Jan 19, 2023, 8:58 AM EST - 2 years ago

5 Health Care Stocks That Are Diving - And May Rally

FATE TECH

Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)

Jan 10, 2023, 7:33 AM EST - 2 years ago

Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)

FATE THRD VERA

Century Therapeutics closes its Seattle hub amid wider cuts, departure of R&D head

Jan 9, 2023, 9:06 PM EST - 2 years ago

Century Therapeutics closes its Seattle hub amid wider cuts, departure of R&D head

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

Jan 5, 2023, 4:01 PM EST - 2 years ago

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Jan 4, 2023, 7:00 AM EST - 3 years ago

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Nov 22, 2022, 7:00 AM EST - 3 years ago

Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates

Nov 11, 2022, 7:00 AM EST - 3 years ago

Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates

Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

Nov 10, 2022, 7:30 AM EST - 3 years ago

Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022

Nov 2, 2022, 7:05 AM EDT - 3 years ago

Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022

Century Therapeutics to Present at the SITC 37th Annual Meeting

Oct 5, 2022, 4:05 PM EDT - 3 years ago

Century Therapeutics to Present at the SITC 37th Annual Meeting

Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors

Oct 3, 2022, 7:00 AM EDT - 3 years ago

Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors

Century Therapeutics to Present at Chardan's 6th Annual Genetic Medicines Conference

Sep 26, 2022, 7:00 AM EDT - 3 years ago

Century Therapeutics to Present at Chardan's 6th Annual Genetic Medicines Conference

Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Sep 6, 2022, 7:00 AM EDT - 3 years ago

Century Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection

Aug 25, 2022, 7:30 AM EDT - 3 years ago

Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection

Invest2live
Invest2live Oct. 8 at 5:04 PM
$CUE $IPSC $LCTX $IPSC 16% already; congrats 🎊🎉🎈🌿 Checkout $CUE and $LCTX
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 8 at 3:51 PM
$IPSC looking good .... break of .60/.62 sends this to .70s this month.
0 · Reply
carpediemjk
carpediemjk Oct. 8 at 2:22 PM
$IPSC Let's go!
0 · Reply
cavindp
cavindp Oct. 8 at 2:18 PM
$IPSC
0 · Reply
Jnutz14
Jnutz14 Oct. 8 at 10:58 AM
$IPSC It is Time!!
0 · Reply
Icarus81
Icarus81 Oct. 8 at 7:32 AM
$IPSC 160m cash + MarketCap 48m + catalyst EOY 👀
0 · Reply
deepgill43
deepgill43 Oct. 8 at 4:48 AM
$IPSC tomorrow is gonna be very interesting day
0 · Reply
BreakoutBuy
BreakoutBuy Oct. 7 at 9:37 PM
I called $RVPH before the run, can $IPSC pop next? 🤨
1 · Reply
BreakoutBuy
BreakoutBuy Oct. 7 at 9:03 PM
$IPSC Some hits in After hours, this wants higher
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 7 at 7:54 PM
$IPSC some more volume into close. Trading way under cash..... this has 2 catalysts ahead. Phase 1 and IND
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 7 at 7:12 PM
$IPSC this is likely to move higher into this month and next month.
1 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 7 at 6:32 PM
$IPSC little pullback is healthy in stocks. This should move higher this month.
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 7 at 1:26 AM
🎯 Target Hit 🏁 📨 From Sep 24, 2025 💊 $IPSC 💵 Entry: $0.4955 ✅ Exit: $0.5764 💰 P/L: +16.32% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Oct. 6 at 8:06 PM
$IPSC strong close today. nice volume as well
1 · Reply
iquitstocktwits
iquitstocktwits Oct. 6 at 7:52 PM
$IPSC i think century therapeutics is next, trading under cash $SPRB
0 · Reply
Kychowsky
Kychowsky Oct. 6 at 7:41 PM
$IPSC New Favorite Stock. If this succeeds, then my lupus nephritis will no longer pose a problem.
0 · Reply
cavindp
cavindp Oct. 6 at 4:58 PM
$IPSC
0 · Reply
revueltoL
revueltoL Oct. 6 at 4:10 PM
$IPSC folks have very modest targets here… my expectations are way too high…skywards! 😀
2 · Reply
brjp
brjp Oct. 6 at 3:58 PM
$IPSC
0 · Reply
The_OG_Stocktwit
The_OG_Stocktwit Oct. 6 at 3:57 PM
$IPSC is it finally gonna do the thing?
0 · Reply
BreakoutBuy
BreakoutBuy Oct. 6 at 3:57 PM
$IPSC Should be over .60s soon. Been consolidating lately and due for a pop
0 · Reply
Kennynails
Kennynails Oct. 6 at 3:54 PM
$IPSC $1 ????
0 · Reply